MyFinsight
Home
Blog
About
Back
Income Statement
ArriVent BioPharma, Inc. (AVBP)
ArriVent BioPharma, Inc. (AVBP)
source: myfinsight.com
Unrealized loss (gain) on
investments
$3K
(400.00%↑ Y/Y)
Total comprehensive
loss
-$49,890K
(-58.89%↓ Y/Y)
Total other
comprehensive loss (gain)
$3K
(400.00%↑ Y/Y)
Net loss
-$49,893K
(-58.90%↓ Y/Y)
Interest and investment
income
$2,798K
(25.81%↑ Y/Y)
Operating loss
-$52,691K
(-56.71%↓ Y/Y)
Total operating
expenses
$52,691K
(56.71%↑ Y/Y)
Research and development
$42,339K
(52.74%↑ Y/Y)
General and
administrative
$10,352K
(75.37%↑ Y/Y)
Back